AI assistant
TENAX THERAPEUTICS, INC. — Director's Dealing 2021
Aug 11, 2021
34835_dirs_2021-08-11_fea4065e-33cf-4419-8d8c-bee1f47ed75b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TENAX THERAPEUTICS, INC. (TENX)
CIK: 0000034956
Period of Report: 2021-06-30
Reporting Person: Doogan Declan (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-30 | Common Stock | G | 567871 | — | Disposed | 2502129 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 567871 | Indirect |
Footnotes
F1: Transaction represents a gift from Dr. Doogan to fund the Declan Doogan 2021 GRAT DTD 03-04-2021 (the "Trust"). Dr. Doogan's wife, Dorothy Doogan, is the trustee of the Trust. Per the terms of the Trust, during its term the Trust must make annuity payments to Dr. Doogan which will be accomplished by transferring shares of common stock back to Dr. Doogan
F2: Dr. Doogan's wife, Dorothy Doogan, is the trustee of the Trust. Dr. Doogan disclaims beneficial ownership of the shares held by the Trust except to the extent of his pecuniary interest therein.